Consumer Finance

FinVolution

FinVolution released FY2025 Q4 earnings on March 16 After-Market (EST), actual revenue USD 432.23 M (forecast USD 439.97 M), actual EPS USD 0.2358

FinVolution released FY2025 Annual Earnings on March 16 After-Market (EST), actual revenue USD 1.907 B (forecast USD 1.941 B), actual EPS USD 1.3445 (forecast USD 1.4148)

FinVolution to Release FY2025 Q4 Earnings on March 16 After-Market EST, Forecast Revenue USD 447.23 M

Xinye Technology Reaches Credit Financing Agreement with HSBC to Expand Financial Services

LeXin Q3 Earnings: AI Boosts Steady Growth, Dividend Ratio Increases

FinVolution released FY2025 9 Months Earnings on November 19 After-Market EST, with actual revenue of USD 1.468 B and EPS of USD 1.1128

FinVolution released FY2025 Q3 earnings on November 19 After-Market EST, actual revenue USD 489.73M, actual EPS USD 0.33

FinVolution to Release FY2025 Q3 Earnings on November 19 After-Market EST

Affirm Technology Hosts 10th AI Algorithm Competition Focusing on Visual Authentication

FinVolution released FY2025 Q2 earnings on August 20 After-Market (EST), actual revenue USD 498.88M, actual EPS USD 0.3904

FinVolution released FY2025 Semi-Annual Earnings on August 20 After-Market EST, actual revenue USD 978.02 M, actual EPS USD 0.7828

Xianyu Technology Reports Q2 2025 Revenue Growth of 12.9% to 360 Million Yuan

FinVolution FY2025 Q2 Earnings Release on August 20, 2025 After-Market EST

Xianyu Technology to Announce 2025 Q2 Financial Results

Xianyu Technology Issued 130 Million US Dollar Convertible Bonds

XinTech Completes $150 Million Convertible Senior Notes Issuance

Xinya Tech Launches Global Data Science Competition

Xianyu Technology Plans to Issue $130 Million Convertible Bonds

XinYi Tech Reports Over 2.38 Billion Yuan Net Profit in 2024, Overseas Business Booms in Q1 2025

Three US-listed Credit Facilitation Companies Release Q1 Earnings Report

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Earning Release Date

财报预告

FY2026 Q1 Earning Release 2026.05.25 (EST)

FinVolution Group (FINV.US) Q2 2025 Earnings Conference Call

FinVolution Group (FINV.US) Q1 2025 Earnings Conference Call

FinVolution Group (FINV.US) Q4 2024 Earnings Conference Call

FinVolution Group (FINV.US) Q3 2024 Earnings Conference Call

FINV

FinVolution Group to Report First Quarter 2026 Financial Results on Monday, May 25, 2026 | FINV Stock News

StockTitan

FinVolution Group to Report First Quarter 2026 Financial Results on Monday, May 25, 2026 | FINV Stock News

FinVolution Group's FY25 results show revenue and operating income declines due to regulatory and credit pressures in China, while international operations now contribute 25% of total revenue and $15 million in profit. Despite higher costs abroad, the international segment's profitability led to a cautious buy rating. The company projects a revenue decline for 2026, reflecting ongoing domestic challenges. Analysts estimate a fair value of $7.61 per share, indicating a potential 50% upside. Investors are advised to consider various perspectives before making decisions.

Simplywall

The Bull Case For FinVolution Group (FINV) Could Change Following Mixed FY25 Results And Rising Overseas Profitability - Learn Why

FINX

ARKF

FinVolution Group has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the SEC. The report is accessible on the SEC's website and the Company's investor relations site. FinVolution, a leading fintech platform in China, connects young borrowers with financial institutions and has 239.6 million registered users. Shareholders can request a hard copy of the report containing audited financial statements free of charge.

prnewswire

Global X Fintech

ARK Fintech Innovation ETF

16:30 ETFinVolution Group Files 2025 Annual Report on Form 20-F

HSAI

MVST

ATAT

ACMR

Hesai(HSAI) rose 4.79%, with a trading turnover 44.4 Million USD, and a year-to-date rose 4.5%. FinVolution(FINV) rose 4.37%, with a trading turnover 5.3 Million USD, and a year-to-date rose 2.1%. Burning Rock Biotech(BNR) fell 7.88%, with a trading turnover 1.4 Million USD, and a year-to-date fell 5.4%. Atour(ATAT) fell 5.48%, with a trading turnover 64.4 Million USD, and a year-to-date fell 6.4%.

- The Nasdaq Composite Index rose by 0.2%, with a year-to-date increase of 7.1%.  
- The S&P 500 Index gained 0.12%, accumulating a 4.8% rise this year, while the Dow Jones Index fell by 0.13%, with a 2.3% year-to-date increase.  
- Notable stock movements included Hesai Technology increasing by 4.79%, Xin Yi Technology rising by 4.37%, while Burning Rock Medical dropped by 7.88% and Atour Lifestyle decreased by 5.48%.

Top Gainers&Losers

Hesai

Accendra Health

Microvast

Burning Rock Biotech

Atour

iQIYI

ACM Research

TAL Edu

Top 5 CDRs Gainers/Losers (>100M) (4.27)

PPDAI Group Inc. (NYSE:FINV) shares gapped down from $5.13 to $4.94 before trading at $4.8280, reflecting a 5.9% decline. Analysts maintain a consensus rating of "Moderate Buy" with a price target of $12.10. The company reported $0.05 EPS and $432.21 million in revenue last quarter. PPDAI also announced an increased annual dividend of $0.306, payable on May 7th. Institutional investors hold 31.15% of the stock, with significant stakes added recently. PPDAI operates an online consumer finance marketplace connecting investors with borrowers.

Market Beat

PPDAI Group (NYSE:FINV) Shares Gap Down   - Time to Sell?

PPDAI Group Inc. (NYSE:FINV) experienced a significant increase in short interest, rising 58.5% in March to 6,377,563 shares. This represents 4.5% of the company's shares sold short, with a days-to-cover ratio of 2.8 days based on an average daily volume of 2,302,974 shares. The stock opened at $4.99, with a market cap of $1.26 billion and a P/E ratio of 3.72. Additionally, PPDAI Group announced an increase in its annual dividend to $0.306, payable on May 7th, up from $0.28.

Short Interest in PPDAI Group Inc. Sponsored ADR (NYSE:FINV) Grows By 58.5%

ZEPP

BIDU

ADAG

Zepp Health(ZEPP) rose 5.9%, with a trading turnover 1.1 Million USD, and a year-to-date fell 54.7%. China Yuchai(CYD) rose 3.78%, with a trading turnover 3.7 Million USD, and a year-to-date rose 20.7%. NIO Inc(NIO) fell 4.86%, with a trading turnover 437.9 Million USD, and a year-to-date rose 19%. Baidu(BIDU) fell 4.65%, with a trading turnover 370.0 Million USD, and a year-to-date fell 17.2%.

- The Nasdaq Composite Index rose by 0.83%, with a year-to-date decrease of 1.8%, while the S&P 500 gained 0.62% and is down 0.3% for the year, and the Dow Jones increased by 0.58% with a 0.3% year-to-date gain.  
- Zepp (ZEPP) experienced a 5.9% increase, totaling $1.111 million in trading volume, but has seen a 54.7% decline this year, whereas Yuchai International (CYD) rose 3.78%, with a trading volume of $3.738 million and a 20.7% year-to-date gain.  
- Nio (NIO) fell by 4.86% with $440 million in trading volume, up 19% this year, and Baidu (BIDU) dropped 4.65% with $370 million in trading volume and a year-to-date decline of 17.2%.

FinVolution(FINV.US)

FinVolution Group to Report First Quarter 2026 Financial Results on Monday, May 25, 2026 | FINV Stock News

The Bull Case For FinVolution Group (FINV) Could Change Following Mixed FY25 Results And Rising Overseas Profitability - Learn Why

16:30 ETFinVolution Group Files 2025 Annual Report on Form 20-F

Top 5 CDRs Gainers/Losers (>100M) (4.27)

PPDAI Group (NYSE:FINV) Shares Gap Down - Time to Sell?

Short Interest in PPDAI Group Inc. Sponsored ADR (NYSE:FINV) Grows By 58.5%

Top 5 CDRs Gainers/Losers (>100M) (4.9)

Trending